check_circleStudy Completed

Dermatitis, Atopic

Bayer Identifier:
Trial_308962
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study to compare the efficacy and safety of Advantan ointment once daily with Protopic 0.03% ointment twice daily in children and adolescents with atopic dermatitis

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

2 - 15 Years

Trial summary

Enrollment Goal
265
Trial Dates
March 2005 - August 2005
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteer
N/A

Trial design

Double-blind, randomized, reference-controlled, multicenter, parallel-group study to compare the efficacy and safety of Advantan ointment once daily with Protopic 0.03% ointment twice daily over maximum 3 weeks in 250 children and adolescents with atopic dermatitis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.